CN106166308B - 一种三维多孔复合支架及其制备方法 - Google Patents
一种三维多孔复合支架及其制备方法 Download PDFInfo
- Publication number
- CN106166308B CN106166308B CN201610715160.3A CN201610715160A CN106166308B CN 106166308 B CN106166308 B CN 106166308B CN 201610715160 A CN201610715160 A CN 201610715160A CN 106166308 B CN106166308 B CN 106166308B
- Authority
- CN
- China
- Prior art keywords
- preparation
- hyaluronic acid
- solution
- protein solution
- silk fibroin
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Active
Links
- 150000001875 compounds Chemical class 0.000 title claims abstract description 55
- 238000002360 preparation method Methods 0.000 title claims abstract description 32
- 108010022355 Fibroins Proteins 0.000 claims abstract description 75
- KIUKXJAPPMFGSW-DNGZLQJQSA-N (2S,3S,4S,5R,6R)-6-[(2S,3R,4R,5S,6R)-3-Acetamido-2-[(2S,3S,4R,5R,6R)-6-[(2R,3R,4R,5S,6R)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2-carboxylic acid Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 KIUKXJAPPMFGSW-DNGZLQJQSA-N 0.000 claims abstract description 33
- 229920002674 hyaluronan Polymers 0.000 claims abstract description 32
- 229960003160 hyaluronic acid Drugs 0.000 claims abstract description 32
- 239000012460 protein solution Substances 0.000 claims abstract description 32
- 239000000243 solution Substances 0.000 claims abstract description 28
- 239000000661 sodium alginate Substances 0.000 claims abstract description 25
- 235000010413 sodium alginate Nutrition 0.000 claims abstract description 25
- 229940005550 sodium alginate Drugs 0.000 claims abstract description 25
- IXPNQXFRVYWDDI-UHFFFAOYSA-N 1-methyl-2,4-dioxo-1,3-diazinane-5-carboximidamide Chemical compound CN1CC(C(N)=N)C(=O)NC1=O IXPNQXFRVYWDDI-UHFFFAOYSA-N 0.000 claims abstract description 23
- 239000011259 mixed solution Substances 0.000 claims abstract description 5
- 239000002994 raw material Substances 0.000 claims abstract description 5
- 239000000203 mixture Substances 0.000 claims abstract description 3
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Chemical compound O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 claims description 45
- 239000008367 deionised water Substances 0.000 claims description 29
- 229910021641 deionized water Inorganic materials 0.000 claims description 29
- AMXOYNBUYSYVKV-UHFFFAOYSA-M lithium bromide Chemical compound [Li+].[Br-] AMXOYNBUYSYVKV-UHFFFAOYSA-M 0.000 claims description 16
- 239000007788 liquid Substances 0.000 claims description 14
- 238000000502 dialysis Methods 0.000 claims description 13
- 238000003756 stirring Methods 0.000 claims description 10
- 239000008236 heating water Substances 0.000 claims description 8
- 238000004108 freeze drying Methods 0.000 claims description 7
- 238000005057 refrigeration Methods 0.000 claims description 6
- 238000002347 injection Methods 0.000 claims description 5
- 239000007924 injection Substances 0.000 claims description 5
- 239000007787 solid Substances 0.000 claims description 5
- DGAQECJNVWCQMB-PUAWFVPOSA-M Ilexoside XXIX Chemical compound C[C@@H]1CC[C@@]2(CC[C@@]3(C(=CC[C@H]4[C@]3(CC[C@@H]5[C@@]4(CC[C@@H](C5(C)C)OS(=O)(=O)[O-])C)C)[C@@H]2[C@]1(C)O)C)C(=O)O[C@H]6[C@@H]([C@H]([C@@H]([C@H](O6)CO)O)O)O.[Na+] DGAQECJNVWCQMB-PUAWFVPOSA-M 0.000 claims description 4
- 229910052708 sodium Inorganic materials 0.000 claims description 4
- 239000011734 sodium Substances 0.000 claims description 4
- 239000006228 supernatant Substances 0.000 claims description 3
- 241000382353 Pupa Species 0.000 claims description 2
- 238000002425 crystallisation Methods 0.000 claims description 2
- 230000008025 crystallization Effects 0.000 claims description 2
- 238000001879 gelation Methods 0.000 claims description 2
- OKTJSMMVPCPJKN-UHFFFAOYSA-N Carbon Chemical compound [C] OKTJSMMVPCPJKN-UHFFFAOYSA-N 0.000 claims 1
- 229910052799 carbon Inorganic materials 0.000 claims 1
- 238000001035 drying Methods 0.000 claims 1
- 239000000463 material Substances 0.000 abstract description 7
- 230000008901 benefit Effects 0.000 abstract description 6
- 239000000126 substance Substances 0.000 abstract description 5
- 230000007812 deficiency Effects 0.000 abstract description 3
- 230000003328 fibroblastic effect Effects 0.000 abstract description 3
- 238000004519 manufacturing process Methods 0.000 abstract description 3
- 230000010148 water-pollination Effects 0.000 abstract description 2
- 210000003491 skin Anatomy 0.000 description 18
- 230000000052 comparative effect Effects 0.000 description 15
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 7
- 230000009514 concussion Effects 0.000 description 7
- 229940059936 lithium bromide Drugs 0.000 description 7
- 238000002156 mixing Methods 0.000 description 7
- 206010018910 Haemolysis Diseases 0.000 description 6
- 238000005119 centrifugation Methods 0.000 description 6
- 239000000701 coagulant Substances 0.000 description 6
- 230000008588 hemolysis Effects 0.000 description 6
- 210000001519 tissue Anatomy 0.000 description 6
- 238000010521 absorption reaction Methods 0.000 description 5
- 230000008859 change Effects 0.000 description 5
- 239000011148 porous material Substances 0.000 description 5
- 150000001408 amides Chemical class 0.000 description 4
- 230000015556 catabolic process Effects 0.000 description 4
- 210000004027 cell Anatomy 0.000 description 4
- 238000006731 degradation reaction Methods 0.000 description 4
- 238000002474 experimental method Methods 0.000 description 4
- 230000008439 repair process Effects 0.000 description 4
- 230000037380 skin damage Effects 0.000 description 4
- 229960001126 alginic acid Drugs 0.000 description 3
- 235000010443 alginic acid Nutrition 0.000 description 3
- 239000000783 alginic acid Substances 0.000 description 3
- 229920000615 alginic acid Polymers 0.000 description 3
- 150000004781 alginic acids Chemical class 0.000 description 3
- 239000006285 cell suspension Substances 0.000 description 3
- 230000007547 defect Effects 0.000 description 3
- 210000003743 erythrocyte Anatomy 0.000 description 3
- 230000031700 light absorption Effects 0.000 description 3
- 239000003755 preservative agent Substances 0.000 description 3
- 230000002335 preservative effect Effects 0.000 description 3
- 238000007789 sealing Methods 0.000 description 3
- 102000004190 Enzymes Human genes 0.000 description 2
- 108090000790 Enzymes Proteins 0.000 description 2
- 238000005033 Fourier transform infrared spectroscopy Methods 0.000 description 2
- 206010072170 Skin wound Diseases 0.000 description 2
- 208000027418 Wounds and injury Diseases 0.000 description 2
- 238000002835 absorbance Methods 0.000 description 2
- 238000004458 analytical method Methods 0.000 description 2
- 230000004888 barrier function Effects 0.000 description 2
- 210000004369 blood Anatomy 0.000 description 2
- 239000008280 blood Substances 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 238000005516 engineering process Methods 0.000 description 2
- 238000000034 method Methods 0.000 description 2
- 239000013642 negative control Substances 0.000 description 2
- 210000000056 organ Anatomy 0.000 description 2
- 239000013641 positive control Substances 0.000 description 2
- YWIVKILSMZOHHF-QJZPQSOGSA-N sodium;(2s,3s,4s,5r,6r)-6-[(2s,3r,4r,5s,6r)-3-acetamido-2-[(2s,3s,4r,5r,6r)-6-[(2r,3r,4r,5s,6r)-3-acetamido-2,5-dihydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-2-carboxy-4,5-dihydroxyoxan-3-yl]oxy-5-hydroxy-6-(hydroxymethyl)oxan-4-yl]oxy-3,4,5-trihydroxyoxane-2- Chemical compound [Na+].CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O[C@H]1[C@H](O)[C@@H](O)[C@H](O[C@H]2[C@@H]([C@@H](O[C@H]3[C@@H]([C@@H](O)[C@H](O)[C@H](O3)C(O)=O)O)[C@H](O)[C@@H](CO)O2)NC(C)=O)[C@@H](C(O)=O)O1 YWIVKILSMZOHHF-QJZPQSOGSA-N 0.000 description 2
- 230000029663 wound healing Effects 0.000 description 2
- AEMOLEFTQBMNLQ-AZLKCVHYSA-N (2r,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-AZLKCVHYSA-N 0.000 description 1
- AEMOLEFTQBMNLQ-SYJWYVCOSA-N (2s,3s,4s,5s,6r)-3,4,5,6-tetrahydroxyoxane-2-carboxylic acid Chemical compound O[C@@H]1O[C@H](C(O)=O)[C@@H](O)[C@H](O)[C@@H]1O AEMOLEFTQBMNLQ-SYJWYVCOSA-N 0.000 description 1
- 108010037362 Extracellular Matrix Proteins Proteins 0.000 description 1
- 102000010834 Extracellular Matrix Proteins Human genes 0.000 description 1
- 229920002683 Glycosaminoglycan Polymers 0.000 description 1
- 238000004566 IR spectroscopy Methods 0.000 description 1
- 208000032984 Intraoperative Complications Diseases 0.000 description 1
- 208000025865 Ulcer Diseases 0.000 description 1
- 206010052428 Wound Diseases 0.000 description 1
- 230000009471 action Effects 0.000 description 1
- 239000005030 aluminium foil Substances 0.000 description 1
- 230000033228 biological regulation Effects 0.000 description 1
- 230000015572 biosynthetic process Effects 0.000 description 1
- 230000000740 bleeding effect Effects 0.000 description 1
- 210000000988 bone and bone Anatomy 0.000 description 1
- 210000000845 cartilage Anatomy 0.000 description 1
- 238000002659 cell therapy Methods 0.000 description 1
- 230000001684 chronic effect Effects 0.000 description 1
- 239000002131 composite material Substances 0.000 description 1
- 230000001010 compromised effect Effects 0.000 description 1
- 210000002808 connective tissue Anatomy 0.000 description 1
- 230000006378 damage Effects 0.000 description 1
- 238000011161 development Methods 0.000 description 1
- 239000003814 drug Substances 0.000 description 1
- 210000002615 epidermis Anatomy 0.000 description 1
- 210000002744 extracellular matrix Anatomy 0.000 description 1
- 210000000630 fibrocyte Anatomy 0.000 description 1
- 230000006870 function Effects 0.000 description 1
- 238000001415 gene therapy Methods 0.000 description 1
- 238000000227 grinding Methods 0.000 description 1
- 238000010438 heat treatment Methods 0.000 description 1
- -1 hyaluronic acid benzyl ester Chemical class 0.000 description 1
- 230000002209 hydrophobic effect Effects 0.000 description 1
- 238000005213 imbibition Methods 0.000 description 1
- 238000000338 in vitro Methods 0.000 description 1
- 208000014674 injury Diseases 0.000 description 1
- 150000002500 ions Chemical class 0.000 description 1
- 210000002510 keratinocyte Anatomy 0.000 description 1
- 201000010260 leiomyoma Diseases 0.000 description 1
- 229920002521 macromolecule Polymers 0.000 description 1
- 238000012986 modification Methods 0.000 description 1
- 230000004048 modification Effects 0.000 description 1
- 230000001537 neural effect Effects 0.000 description 1
- 210000003924 normoblast Anatomy 0.000 description 1
- 206010033675 panniculitis Diseases 0.000 description 1
- 230000008447 perception Effects 0.000 description 1
- 239000002861 polymer material Substances 0.000 description 1
- 229920001282 polysaccharide Polymers 0.000 description 1
- 239000005017 polysaccharide Substances 0.000 description 1
- 150000004804 polysaccharides Chemical class 0.000 description 1
- 230000035755 proliferation Effects 0.000 description 1
- 239000011814 protection agent Substances 0.000 description 1
- 108090000623 proteins and genes Proteins 0.000 description 1
- 102000004169 proteins and genes Human genes 0.000 description 1
- 230000009467 reduction Effects 0.000 description 1
- 230000001172 regenerating effect Effects 0.000 description 1
- 238000011160 research Methods 0.000 description 1
- 238000009738 saturating Methods 0.000 description 1
- 206010040872 skin infection Diseases 0.000 description 1
- 230000003595 spectral effect Effects 0.000 description 1
- 238000001228 spectrum Methods 0.000 description 1
- 210000004304 subcutaneous tissue Anatomy 0.000 description 1
- 238000001356 surgical procedure Methods 0.000 description 1
- 238000002411 thermogravimetry Methods 0.000 description 1
- 231100000397 ulcer Toxicity 0.000 description 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/40—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material
- A61L27/44—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix
- A61L27/48—Composite materials, i.e. containing one material dispersed in a matrix of the same or different material having a macromolecular matrix with macromolecular fillers
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/56—Porous materials, e.g. foams or sponges
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61L—METHODS OR APPARATUS FOR STERILISING MATERIALS OR OBJECTS IN GENERAL; DISINFECTION, STERILISATION OR DEODORISATION OF AIR; CHEMICAL ASPECTS OF BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES; MATERIALS FOR BANDAGES, DRESSINGS, ABSORBENT PADS OR SURGICAL ARTICLES
- A61L27/00—Materials for grafts or prostheses or for coating grafts or prostheses
- A61L27/50—Materials characterised by their function or physical properties, e.g. injectable or lubricating compositions, shape-memory materials, surface modified materials
- A61L27/60—Materials for use in artificial skin
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Transplantation (AREA)
- Epidemiology (AREA)
- Veterinary Medicine (AREA)
- Dermatology (AREA)
- Medicinal Chemistry (AREA)
- Oral & Maxillofacial Surgery (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Materials Engineering (AREA)
- Engineering & Computer Science (AREA)
- Composite Materials (AREA)
- Dispersion Chemistry (AREA)
- Materials For Medical Uses (AREA)
Abstract
Description
V<sub>0</sub> | Dry weight±SD(mg) | V±SD(ml) | R±SD |
10 | 35.74±6.34 | 8.5±0.23 | 41.97±0.86 |
Claims (10)
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610715160.3A CN106166308B (zh) | 2016-08-24 | 2016-08-24 | 一种三维多孔复合支架及其制备方法 |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201610715160.3A CN106166308B (zh) | 2016-08-24 | 2016-08-24 | 一种三维多孔复合支架及其制备方法 |
Publications (2)
Publication Number | Publication Date |
---|---|
CN106166308A CN106166308A (zh) | 2016-11-30 |
CN106166308B true CN106166308B (zh) | 2019-01-18 |
Family
ID=57376743
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201610715160.3A Active CN106166308B (zh) | 2016-08-24 | 2016-08-24 | 一种三维多孔复合支架及其制备方法 |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN106166308B (zh) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113975461B (zh) * | 2021-12-01 | 2022-04-01 | 四川大学 | 一种可招募内源性间充质干细胞的支架材料及其制备方法与应用 |
CN114316162B (zh) * | 2022-01-18 | 2023-06-13 | 四川大学 | 光交联可注射纳米纤维-水凝胶复合物及其制备方法与应用 |
Family Cites Families (6)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
EP2210971A1 (en) * | 2009-01-26 | 2010-07-28 | Politecnico Di Milano | Silk fibroin textile structures as biomimetic prosthetics for the regeneration of tissues and ligaments |
CN101700409A (zh) * | 2009-11-20 | 2010-05-05 | 佘振定 | 一种由纯天然材料制备的创伤用材料 |
CN102178980A (zh) * | 2011-05-05 | 2011-09-14 | 东南大学 | 天然高分子复合多孔纤维支架及其制备方法 |
CN103225126B (zh) * | 2013-05-14 | 2014-10-22 | 浙江大学 | 丝素/海藻酸钠复合纳米纤维支架的制备方法 |
CN103469351B (zh) * | 2013-07-18 | 2016-03-02 | 嘉兴学院 | 负载维生素c的丝素蛋白/透明质酸复合纳米纤维的制备方法 |
CN105521525B (zh) * | 2015-12-16 | 2019-01-25 | 广州创赛生物医用材料有限公司 | 一种骨组织工程用多孔复合支架及其制备方法 |
-
2016
- 2016-08-24 CN CN201610715160.3A patent/CN106166308B/zh active Active
Also Published As
Publication number | Publication date |
---|---|
CN106166308A (zh) | 2016-11-30 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
US9555164B2 (en) | Method for preparing porous scaffold for tissue engineering | |
Zhang et al. | Silk fibroin microfibers and chitosan modified poly (glycerol sebacate) composite scaffolds for skin tissue engineering | |
CN109999227B (zh) | 一种基于丝素蛋白和甲壳素混纺纳米纤维嵌入式水凝胶软骨仿生支架的制备方法及应用 | |
CN102277737A (zh) | 聚己内酯/天然高分子复合多孔支架的制备方法及应用 | |
CN101084025A (zh) | 多孔生物材料-填充物复合物及其制造方法 | |
CN106860915B (zh) | 一种透明质酸寡糖修饰的矿化胶原仿生骨修复材料及其制备方法 | |
Xie et al. | Adult stem cells seeded on electrospinning silk fibroin nanofiberous scaffold enhance wound repair and regeneration | |
CN103083723B (zh) | 胶原/纳米纤维素皮肤再生材料及其制备方法与应用 | |
CN104001208B (zh) | 一种生物可降解高分子/甲壳素纳米晶复合支架材料的制备方法 | |
CN102218160A (zh) | 神经组织基质源性组织工程支架材料的制备及其应用 | |
CN104984393B (zh) | 一种骨组织工程支架材料及其制备方法 | |
CN114225116B (zh) | 一种可缓释透明质酸和生长因子的人工骨膜及其制备方法 | |
CN109381732A (zh) | 负载生长因子小分子抑制剂的静电纺丝敷料、其制备方法及应用 | |
CN106166308B (zh) | 一种三维多孔复合支架及其制备方法 | |
CN108744061B (zh) | 一种负载bmp-2的掺锶羟基磷灰石/丝素蛋白/肝素复合支架及其制备方法和应用 | |
He et al. | Silk fibroin/chitosan/TGF-β1-loaded microsphere scaffolds for cartilage reparation | |
CN110975009B (zh) | 静电纺丝纤维支架材料的制备方法 | |
CN112494712A (zh) | 一种具有止血和促骨愈合功能的可吸收海绵状骨蜡及其制备方法 | |
CN112870429A (zh) | 一种壳聚糖基聚电解质复合止血海绵、制备方法和应用 | |
CN113952512B (zh) | 一种复合多孔凝胶微球及其制备方法和应用 | |
CN114053486B (zh) | 一种可吸收生物活性膜及其制备方法和用途 | |
CN110624129B (zh) | 一种耐溶蚀的骨诱导性丝素蛋白/羟基磷灰石/氧化镁凝胶海绵及制备方法 | |
CN113018517A (zh) | 一种3d打印皮肤支架及其制备方法和应用 | |
CN117339013B (zh) | 一种能提高软骨修复能力的水凝胶复合支架 | |
CN116747355B (zh) | 一种复合人工皮肤及其制备方法 |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
C06 | Publication | ||
PB01 | Publication | ||
C10 | Entry into substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant | ||
CP03 | Change of name, title or address |
Address after: 510663 floor 2, building C, building 1, No. 2, Ruitai Road, Guangzhou hi tech Industrial Development Zone, Guangdong Province Patentee after: Guangzhou bioscience Co.,Ltd. Address before: High tech Industrial Development Zone, Guangzhou City, Guangdong province 510663 Science City skim Springs Road No. 3, Guangzhou international business incubator A A506 Patentee before: GUANGZHOU BEOGENE BIOTECH Co.,Ltd. |
|
CP03 | Change of name, title or address | ||
TR01 | Transfer of patent right |
Effective date of registration: 20200417 Address after: 510663 floor 2, building C, building 1, No. 2, Ruitai Road, Guangzhou hi tech Industrial Development Zone, Guangdong Province Co-patentee after: GUANGZHOU CHUANGSEED BIOMATERIALS CO.,LTD. Patentee after: Guangzhou bioscience Co.,Ltd. Address before: 510663 floor 2, building C, building 1, No. 2, Ruitai Road, Guangzhou hi tech Industrial Development Zone, Guangdong Province Patentee before: Guangzhou bioscience Co.,Ltd. |
|
TR01 | Transfer of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A three dimensional porous composite scaffold and its preparation method Effective date of registration: 20210407 Granted publication date: 20190118 Pledgee: Zhongda sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: GUANGZHOU CHUANGSEED BIOMATERIALS Co.,Ltd.|Guangzhou bioscience Co.,Ltd. Registration number: Y2021440000120 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right | ||
PC01 | Cancellation of the registration of the contract for pledge of patent right |
Date of cancellation: 20220713 Granted publication date: 20190118 Pledgee: Zhongda sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: GUANGZHOU CHUANGSEED BIOMATERIALS CO.,LTD.|Guangzhou bioscience Co.,Ltd. Registration number: Y2021440000120 |
|
PC01 | Cancellation of the registration of the contract for pledge of patent right | ||
PE01 | Entry into force of the registration of the contract for pledge of patent right |
Denomination of invention: A three-dimensional porous composite scaffold and its preparation method Effective date of registration: 20220713 Granted publication date: 20190118 Pledgee: Zhongda sub branch of Bank of Guangzhou Co.,Ltd. Pledgor: GUANGZHOU CHUANGSEED BIOMATERIALS CO.,LTD.|Guangzhou bioscience Co.,Ltd. Registration number: Y2022980010456 |
|
PE01 | Entry into force of the registration of the contract for pledge of patent right |